Cargando…
After Proper Optimization of Carvedilol dose, do Different Child Classes of Liver Disease Differ in Terms of dose Tolerance and Response on a Chronic Basis?
BACKGROUND/AIMS: Literature regarding safe doses of carvedilol is limited, and safe doses across different Child classes of chronic liver disease are not clear. PATIENTS AND METHODS: A total of 102 consecutive cirrhotic patients with significant portal hypertension were included in this study. Hepat...
Autores principales: | Wani, Zeeshan A., Baht, Riyaz A., Bhadoria, Ajeet S., Maiwall, Rakhi, Majeed, Yamin, Khan, Afaq A., Zargar, Showkat A., Shah, Mohd A., Khan, Kaiser M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632251/ https://www.ncbi.nlm.nih.gov/pubmed/26458853 http://dx.doi.org/10.4103/1319-3767.164207 |
Ejemplares similares
-
Extrahepatic Portal Vein Obstruction and Portal Vein Thrombosis in Special Situations: Need for a New Classification
por: Wani, Zeeshan A., et al.
Publicado: (2015) -
Gastric varices: Classification, endoscopic and ultrasonographic management
por: Wani, Zeeshan Ahmad, et al.
Publicado: (2015) -
Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
por: Wani, Zeeshan Ahmad, et al.
Publicado: (2017) -
Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension
por: Cheong, Hoi I, et al.
Publicado: (2018) -
Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation
por: Chitrapu, Ravi Venkatachelam, et al.
Publicado: (2014)